Shinva Medical InstrumentLtd Management

Management criteria checks 2/4

Shinva Medical InstrumentLtd's CEO is Baoxian Gong, appointed in Feb 2022, has a tenure of 2.25 years. directly owns 0.009% of the company’s shares, worth CN¥952.67K. The average tenure of the management team and the board of directors is 4.1 years and 3.8 years respectively.

Key information

Baoxian Gong

Chief executive officer

CN¥2.0m

Total compensation

CEO salary percentage	n/a
CEO tenure	2.3yrs
CEO ownership	0.009%
Management average tenure	4.1yrs
Board average tenure	3.8yrs

Recent management updates

Recent updates

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Mar 28

CEO

Baoxian Gong (47 yo)

2.3yrs

Tenure

CN¥1,958,200

Compensation

Mr. Baoxian Gong is General Manager of Shinva Medical Instrument Co., Ltd., since February 23, 2022.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Baoxian Gong	General Manager	2.3yrs	CN¥1.96m	0.0086% CN¥ 952.7k
Juanjuan Zhou	CFO & Director	no data	CN¥657.60k	0.020% CN¥ 2.3m
Cai Xiang Li	Deputy GM & Secretary of the Board	9.9yrs	CN¥1.23m	0.036% CN¥ 4.0m
Zhao Xu Yang	Deputy General Manager	no data	CN¥1.25m	0.015% CN¥ 1.6m
Jing Qu	Deputy General Manager	4.1yrs	CN¥1.55m	0.022% CN¥ 2.4m
Jiaqiang Wang	Deputy General Manager	no data	CN¥1.52m	0.0096% CN¥ 1.1m
Qingguo Zhu	Deputy General Manager	no data	CN¥1.09m	0.011% CN¥ 1.2m

4.1yrs

Average Tenure

47yo

Average Age

Experienced Management: 600587's management team is considered experienced (4.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Juanjuan Zhou	CFO & Director	no data	CN¥657.60k	0.020% CN¥ 2.3m
Ailing Pan	Independent Director	3.8yrs	CN¥80.00k	no data
Yu Quan Wang	Chairman	4yrs	CN¥1.56m	0.035% CN¥ 3.9m
Weijun Gu	Independent Director	3.9yrs	CN¥80.00k	0.0011% CN¥ 118.9k
Hongtao Cui	Employee Representative Director	7.1yrs	CN¥2.60m	0.023% CN¥ 2.6m
Xiao Li Zhao	Director	7.1yrs	CN¥1.02m	no data
Yueyong Wang	Director	3.3yrs	no data	no data
Xiao Li Li	Director	3.3yrs	CN¥554.90k	no data
Li Yong Jiang	Independent Director	3.3yrs	CN¥80.00k	no data
Lehai Mou	Chairman of the Supervisory Board	3.3yrs	no data	no data
Gongzhuo Zhao	Employee Supervisor	4.1yrs	no data	0.00011% CN¥ 12.2k
Yuan Li	Independent Director	2.8yrs	CN¥80.00k	no data

3.8yrs

Average Tenure

55.5yo

Average Age

Experienced Board: 600587's board of directors are considered experienced (3.8 years average tenure).

Shinva Medical InstrumentLtd Management

Management criteria checks 2/4

Key information

Recent management updates

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

First quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.46 in 1Q 2023)

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Investor sentiment deteriorates as stock falls 19%

Shinva Medical Instrument Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.24 in 3Q 2022)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.57 (vs CN¥0.48 in 2Q 2022)

New minor risk - Dividend sustainability

Full year 2022 earnings released: EPS: CN¥1.23 (vs CN¥1.37 in FY 2021)

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.48 (vs CN¥0.45 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to CN¥41.65

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.25 in 2Q 2020)

Investor sentiment improved over the past week

Zou Huiling acquired 16.67% stake in Beijing Huaco Healthcare Technologies Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 25 million.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.08 in 1Q 2020)

New 90-day low: CN¥12.23

New 90-day low: CN¥13.25

New 90-day low: CN¥14.41

New 90-day low: CN¥14.78

New 90-day low: CN¥15.88

Third quarter earnings released

Shinva Medical Instrument Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

First half earnings released

Nanyang Great Health Medical Care Industry Development Co., Ltd acquired 80% stake in Nanyang Orthopedics High-tech Zone Hospital Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 53.8 million.

New 90-day high - CN¥18.41

Shinva Medical Instrument Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age